McKesson’s proactive approach to drug supply constraints: 3 insights

Healthcare supplier McKesson formed a Critical Care Drug Task Force to proactively manage pharmaceutical supply constraints during the pandemic, according to an Oct. 27 announcement.

Advertisement

What you should know:

1. The task force compares the number of COVID-19 cases on local and national levels with customer demand patterns to forecast supply needs for pharmaceutical manufacturers.

2. The strategy was developed in response to pandemic-induced purchasing increases and is intended to help hospital customers remain prepared to treat COVID-19 patients.

3. The cross-functional team will continue meeting indefinitely.

More articles on surgery centers:
The ASC in 2021: 3 expert predictions on cardiology
10 lowest-paying cities for physicians
ASC valuation multiples continue to rise & more — 12 ASC industry notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply chain

Advertisement

Comments are closed.